S&P 및 Nasdaq 내재가치 문의하기

Satsuma Pharmaceuticals, Inc. STSA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
23/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Satsuma Pharmaceuticals, Inc. (STSA) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 THL Equity Advisors VI, LLC 854,575,000 주 보유. 기타 주요 보유자에는 Thomas H. Lee Equity Fund VI, L.P. 및 TAKANASHI KEN.

STSA 내부자 보유 현황

최대 보유자
THL Equity Advisors VI, LLC
854,575,000 주
매수 (12개월)
0
$0.00 평가액
매도 (12개월)
0
$0.00 평가액
내부자 주요 보유자
# 이름 직책 보유 주식수 최종 신고일 상대적 규모
1 Thl Equity Advisors Vi, Llc 10 Percent Owner 854,575,000 2010-11-24
100%
2 Thomas H. Lee Equity Fund Vi, L.p. 10 Percent Owner 470,908,524 2010-11-24
55%
3 Takanashi Ken 10 Percent Owner 24,847,694 2023-06-08
3%
4 Shin Nippon Biomedical Laboratories, Ltd. 10 Percent Owner 22,053,581 2023-06-08
3%
5 Kollins John A President and CEO 505,000 2022-06-07
0%
6 Commodore Capital Lp Director 461,286 2022-11-16
0%
7 O'neil Thomas P. Chief Financial Officer 190,000 2022-06-07
0%
8 Albrecht Detlef Chief Medical Officer 190,000 2022-06-07
0%
9 Leonard Braden Michael Director 150,000 2022-11-23
0%
10 Stanley Heidi B CEO/chair of Sterling Savings 70,212 2009-10-15
0%
11 Shah Rajeev M. Director 30,000 2022-06-07
0%
12 Riebe Michael T Director 30,000 2022-06-07
0%
13 Soloway Thomas P Director 30,000 2022-06-07
0%
14 Ra Capital Management, L.p. 10 Percent Owner 30,000 2022-06-07
0%
15 Harsch Mutya Director 30,000 2022-06-07
0%
16 Lukatch Heath Director 30,000 2022-06-07
0%
17 King Thomas Braxton Director 30,000 2022-06-07
0%
18 Sandoval Elisabeth Director 30,000 2022-06-07
0%
19 Seibly John Gregory CEO/president - Sfc 15,784 2014-04-08
0%
20 Eckhardt Ezra COO - Sterling Financial Corp. 9,771 2014-04-08
0%

STSA의 보유 데이터가 없습니다.

문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기